Last reviewed · How we verify

NCT06737679: SCAN-HF

The Effects of Body Scan on Enteroception in Patients With Heart Failure

Recruiting now NA Last updated 7 February 2025
What this trial tests

NA trial testing Body Scan in Heart Failure in 110 participants. Currently enrolling.

Timeline
28 January 2025
Primary endpoint
7 March 2025
31 January 2026

Quick facts

Lead sponsorCentro Cardiologico Monzino
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment110
Start date28 January 2025
Primary completion7 March 2025
Estimated completion31 January 2026
Sites2 locations across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Centro Cardiologico Monzino — full company profile →

Who can join

Adults 18 to 75, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to explore the effects of body scan on enteroception in people with heart failure

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Body Scan

Trials testing the same drug.

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

Other Centro Cardiologico Monzino trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06737679.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing